z-logo
open-access-imgOpen Access
Does positioning of chromosomes 8 and 21 in interphase drive t(8;21) in acute myelogenous leukemia?
Author(s) -
Moneeb A. K. Othman,
Amelie Lier,
Susann Junker,
Philipp Kempf,
Franziska Dorka,
Erich Gebhart,
Frenny Sheth,
Beata Grygalewicz,
Samarth Bhatt,
Anja Weise,
Kristin Mrasek,
Thomas Liehr,
Marina Manvelyan
Publication year - 2012
Publication title -
biodiscovery
Language(s) - English
Resource type - Journals
ISSN - 2050-2966
DOI - 10.7750/biodiscovery.2012.4.2
Subject(s) - interphase , myeloid leukemia , chromosomal translocation , fluorescence in situ hybridization , bone marrow , biology , cancer research , chromosome , myeloid , genetics , gene , immunology
The impact of chromosome architecture in the formation of chromosome aberrations is a recent finding of interphase directed molecular cytogenetic studies. There evidence was provided that disease specific chromosomal translocations could be due to tissue specific genomic organization. In a recent small pilot study using three-dimensional interphase fluorescence in situ hybridization, we showed that there might be a specific chromosome positioning in myeloid bone marrow cells, i.e. a co-localization of chromosomes 8 and 21. Here we could substantiate this finding in overall 21 studied cases with acute myeloid leukemia (AML) that there is even a co-localization of the genes AML1 and ETO. This finding led to the suggestion that a specific interphase architecture of myeloid bone marrow cells might promote the typical t(8;21)(q22;q22) leading to AML-M2

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom